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INTRODUCTION
Most Escherichia coli are harmless commensals of
the gastrointestinal flora of warm-blooded animals and
humans. However, some subsets of E. coli have acqui-
red virulence properties that render them capable of
causing a variety of clinical outcomes in humans and
animals. Most acquired virulence factors that distin-
guish pathogenic E. coli from harmless E. coli are en-
coded on mobile genetic elements capable of horizon-
tal gene transfer or on elements that were once mobile
and subsequently evolved to be a stable part of the ge-
nome (Kaper et al., 2004). The intestinal E. coli pa-
thogens can be divided into six well defined patho types:
enterohemorrhagic E. coli (EHEC), entero patho genic E.
coli (EPEC), enterotoxigenic E. coli (ETEC), entero-
aggregative E. coli (EAggEC), diffusely adherent E.
coli (DAEC), and enteroinvasive E. coli (EIEC) (Nataro
and Kaper, 1998). The differences between these pa-
thotypes are not discussed in this review since the fo-
cus is on the EHEC pathotype and the enteroaggrega-
tive verotoxin-producing E. coli O104:H4 outbreak
strain.
PATHOGENIC FEATURES AND VIRULENCE
FACTORS OF EHEC
EHEC denotes strains that are associated with he-
morrhagic colitis and the hemolytic uremic syndrome
in humans, and express verocytotoxins and colonize
the intestine by causing typical attaching-effacing
(A/E) lesions (Nataro and Kaper, 1998). The majority
of clinical cases have been caused by strains belonging
to the O157:H7 serotype. However, there are a num-
ber of non-O157 serogroups of which the 4 deemed
most important in terms of clinical infections are O26,
O103, O111 and O145. Nevertheless, there are many
other sero groups, such as O91, O121 and recently
O104, which have also caused infections.
Verocytotoxins
The cardinal trait of EHEC is the production of
verocytotoxins. The definition is based upon the pro-
duction of toxins with a cytotoxic activity against vero
cells. There are two main types, namely VT1 and VT2
that can be further divided into subtypes based on their
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ABSTRACT
This review deals with the epidemiology and ecology of enterohemorrhagic Escherichia coli (EHEC), a
subset of the verocytotoxigenic Escherichia coli (VTEC), and subsequently discusses its public health concern.
Attention is also given to the outbreak strain O104:H4, which has been isolated as causative agent of the
second largest outbreak of the hemolytic uremic syndrome worldwide, which started in Germany in May
2011. This outbreak strain is not an EHEC as such but possesses an unusual combination of EHEC and
enteroaggregative E. coli (EAggEC) virulence properties. 
SAMENVATTING
In dit overzichtsartikel worden de epidemiologie en de ecologie van de enterohemorragische Escherichia coli
(EHEC), een subset van de verocytotoxigene E. coli (VTEC) besproken en wordt het belang ervan voor de
volksgezondheid toegelicht. Speciale aandacht wordt besteed aan de uitbraakstam O104:H4 die geïsoleerd werd als
verwekker van de tweede grootste uitbraak van het hemolytische uremisch syndroom wereldwijd. Deze uitbraak
begon in mei 2011 in Duitsland maar hield heel Europa in de ban. Deze stam is echter geen EHEC als dusdanig, maar
bezit een ongewone combinatie van virulentiefactoren van zowel EHEC als enteroaggregatieve E. coli.
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sequence analyses. The nomenclature is not definite
and new variants are constantly being described. The
VT1 family can be divided into three subtypes, namely
VT1, VT1c and VT1d (Muthing et al., 2009). The
VT2 is more heterogeneous and up to now, it has been
divided into 7 subtypes, namely VT2, VT2b, VT2c,
VT2d, VT2e, Vt2f and VT2g (Mainil and Daube, 2005;
Persson et al., 2007). The VT-encoding genes (vtx)
are generally encoded by a heterogeneous group of
temperate lambdoid bacteriophages and are expressed
when the lytic cycle is activated (Allison, 2007; Her-
old et al., 2004). The VT-encoding vtx2e was initially
thought to be chromosomally encoded (Paton and Pa-
ton, 1998). However, a vtx2e converting bacterio phage
has been isolated (Muniesa et al., 2000). Several stu-
dies have demonstrated a correlation between the toxin
subtypes, severity of clinical diseases and seropatho-
types. In general, EHEC producing VT2 only, generally
cause more severe disease than those producing lonely
VT1 or both VT1 and VT2 (Table 1). 
Although the production of VT is considered a main
virulence factor of EHEC, strains of non-verocytotoxin
producing E. coli O157:H- have been isolated from pa-
tients with HUS or diarrhoea (Schmidt et al. 1999b).
However, Joris et al. (2011) have demonstrated the
spontaneous loss of vtx genes during isolation. This
might complicate the characterization of the virulence
patterns of these strains. They can appear to be vtx ne-
gative but clinically and epidemiologically they are ori-
ginally vtx positive strains.
All VT belong to the AB5 family of toxins, with the
A subunit carrying the enzymatic activity and a penta-
meric receptor-binding B subunit. The pentameric B
subunit binds specifically to the globotriaosylceramide
(Gb3) and globotetraosylceramide (Gb4) receptor. The
Gb4 receptor is preferred by the VT2e, whereas all
other VT variants prefer Gb3 (Boyd et al., 1993; Ling-
wood et al., 1998). After binding to the receptor, Vt are
internalized by a clathrin-mediated endocytosis and
transported via the Golgi-apparatus to the endoplas-
matic reticulum (Sandvig et al., 1992). In the cytosol,
the A subunit is cleaved by a protease, furin, into a ca-
talytically active A1 fragment and an A2 fragment.
The A1 fragment exerts tRNA N-glycosidase activity
that specifically removes an adenine residue from the
28S rRNA of the 60S ribosome (Endo et al., 1988).
This process inhibits protein synthesis and leads to
cell death.
Locus of enterocyte effacement 
The hallmark of EHEC strains is the induction of
A/E lesions, which are characterized by localized de-
struction of brush border microvilli and intimate at-
tachment to the plasma membrane of host epithelial
cells. EHEC strains share the induction of A/E lesions
Table 1. Different types of VT (adapted from Gyles, 2007).
VT variants Characteristics Reference
Vtx1 VT produced by VTEC and almost identical to Stx produced by (Strockbine et al., 1986)
Shigella dysenteriae serotype 1 
Vtx1c Variant of Vtx1 that is found in ovine and caprine strains (Brett et al., 2003; 
but not in bovine strains and in some eae-negative VTEC; Zhang et al., 2002)
associated with mild diarrhoea or no symptoms
Vtx1d A variant of Vtx1 isolated from bovine and human strains; (Burk et al., 2003)
associated with asymptomatic infections
Vtx2 Prototype of non-Vtx1 toxins; associated with severe disease in humans (Strockbine et al., 1986)
Vtx2c Associated with diarrhoea and HUS in humans; common in bovine (Friedrich et al., 
and ovine VTEC 2002; Pierard et al.,
1998; Schmitt et al., 1991)
Vt2d Associated with eae-negative VTEC and mild disease in human (Friedrich et al., 2002;
Pierard et al., 1998)
Vtx2dact Vero cell cytotoxicity is increased by elastase in intestinal mucus; (Kokai-Kun et al., 2000)
these strains are highly virulent
Vtx2e A variant responsible for oedema disease of pigs; rare in human (Gyles et al., 1988; 
disease and associated with mild diarrhoea or asymptomatic Sonntag et al., 2005a)
infections in humans
Vtx2f A variant frequently isolated from pigeon droppings; rare in human disease (Sonntag et al., 2005b)
Vtx2g A variant isolated from bovine strains; to date not associated with human disease (Leung et al., 2003)
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with EPEC strains. The locus of enterocyte efface-
ment (LEE), which is constituted of three functionally
different components, is the genetic element responsi-
ble for the formation of A/E lesions. The first encodes
a type three secretion system (TTSS) that exports ef-
fector proteins. The second encodes the structural com-
ponents of the type three secretion apparatus, namely
the secreted proteins EspA, B and D. The third enco-
des the 94-kDA outer-membrane protein intimin, en-
coded by eae, which mediate the intimate attachment
of EHEC to the intestinal epithelial cells and its trans-
located receptor Tir, which is directly inserted in the
host cell membrane. 
EHEC IN HUMANS
EHEC infections in humans are associated with a
broad spectrum of clinical outcomes ranging from
symptom-free infection through watery diarrhoea, to
severe hemorrhagic colitis (HC) and hemolytic uremic
syndrome (HUS). The incubation period is three days
(ranging between 1-12 days) (Tarr et al., 2005). Cha-
racteristically, patients suffer the first three days from
watery diarrhoea, abdominal cramps and occasionally
nausea and vomiting. In 90% of the cases, this diarrhoea
becomes hemorrhagic within one to three days. When
bloody diarrhoea develops, the patients has a normal
platelet count, creatinine concentration and packed-cell
volume with no erythrocyte fragmentation (Tarr et al.,
2005). In most cases, recovery from illness usually oc-
curs spontaneously over approximately one week. Ho-
wever, the infection can evolve to the life-threatening
HUS. The classic triad of features for HUS consists of
acute renal failure, microangiopathic hemolytic ane-
mia, and thrombocytopenia. The major risk factors for
acquiring HUS include extremes of age (<15 years or >
65 years) (Dundas and Todd, 2000), early neutrophilia,
hypoalbuminemia (Dundas et al., 2001), increased C re-
active protein level, fever within the first three days of
illness (Ikeda et al., 2000) and the administration of an-
tibiotics and antimotility agents (Wong et al., 2000). The
mortality from HUS is between 3-17%, however in the
elderly, it is as high as 87% (Griffin and Tauxe, 1991).
While the kidney is the organ most commonly affected
in HUS, evidence of central nervous system, pancreatic,
skeletal and myocardial involvement may also be pre-
sent (Richardson et al., 1988; Sebbag et al., 1999; Sie-
gler, 1994). Pancreatic involvement, indicated by insu-
lin-dependent diabetes mellitus and the increase of
pancreatic enzymes, arises in less than 10% of the cases
(Andreoli and Bergstein, 1982). The involvement of
the central nervous system occurs in up to 25% of the
cases and can lead to irritability, learning disabilities, le-
thargy and seizures and in sporadic cases to cerebral
edema and coma (Amirlak and Amirlak, 2006; Elliott
and Robins-Browne, 2005). 
RESERVOIR HOSTS OF EHEC
EHEC are usually found in the colon epithelium of
ruminants, among which cattle are recognized to be the
main reservoir. Carriage rates in cattle appear to be par-
ticularly high (ranging from 0.2 to 70.1%) (Hussein
and Bollinger, 2005) and contamination of foodstuffs
from these animals has been highlighted as a major
source of human infections. However, EHEC has been
isolated from other food-producing, domestic and wild
animals. In addition to the potential for foods derived
from animals becoming contaminated with EHEC,
animals themselves can act as vectors for the spreading
of EHEC in the environment and to humans.
Cattle 
Cattle are generally regarded as the main natural re-
servoir of EHEC. Although most of the EHEC strains
do not cause disease in cattle, some serogroups such
as O5, O26 and O118 are associated with diarrhoea in
calves (Mainil, 1999). The apparent resistance of cattle
to systemic effects of VT may be due to the distinct
pattern of Gb3 receptors in their kidneys and the ab-
sence of receptors on vasculature (Hoey et al., 2002).
Shedding of EHEC in cattle has been shown to be in-
termittent. Most animals that test positive for EHEC
become fecal culture negative within two or three
months (Besser et al., 1997; Rahn et al., 1997). Ne-
vertheless, while shedding among cattle appears trans-
iently, EHEC infection maintains in cattle herds (Wells
et al., 1991). All ages of cattle are susceptible to co-
lonization with EHEC, although peak shedding is ob-
served in subadult cattle from weaning to 24 months
of age (Hussein and Sakuma, 2005). The prevalence
can also be affected by the season, with higher rates
being reported during spring and summer. This sea-
sonal effect has long been theorized to be related to the
increased proliferation of EHEC in the environment
during warm weather (Hancock et al., 1994; Heuve-
link et al., 1998b). However, a recent hypothesis has
emerged that day length and physiological responses
within the animal to changing day length may explain
the seasonal shedding patterns (Edrington et al., 2006).
The study showed that after a period of 60 days, there
was a significant difference in shedding in the lighted
pens compared to control groups with no light-treat-
ment. Once the light-treatment was removed from the
test group, shedding de creased to levels equivalent to
the control group.
Other ruminants
Small ruminants, such as sheep and goats, are also
known carriers of E. coli O157 and non-O157. Com-
pared with cattle, higher prevalence rates for EHEC
have been found in sheep and goats. Beutin et al.
(1993) demonstrated prevalence rates of 56% in goats,
67% in sheep compared to 18% in cattle. In Australia,
in 88% of fecal samples from sheep grazing on pasture
vtx genes were detected (Fegan and Desmarchelier,
1999). Ovine strains belong in general to six sero-
groups, namely O6, O91, O117, O128, O146 and O166
(Heuvelink et al., 1998a; Urdahl et al., 2003). The
water buffalo is another potential source of EHEC in-
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fections. A recent survey conducted in Italy has de-
monstrated that buffalo herds are often colonized by E.
coli O157 (Galiero et al., 2005). Based on the current
preliminary prevalence rates, it is reasonable to as-
sume small ruminants to be a potential source of human
EHEC infections. However, given the preliminary cha-
racter of the prevalence rates, further research may be
warranted.
Non-ruminants
EHEC have been occasionally isolated from animals
other than ruminants. In many cases, it is not clear whe-
ther they are actual hosts of the bacteria or merely act as
vectors after contact with contaminated feces (Wasteson,
2008; Wasteson et al., 1999; Wasteson et al., 1992).
Johnsen et al. (2001) isolated E. coli O157 in 0.1%
from pigs raised at farms that also bread cattle. In the
United States, a recovery rate of 2% was observed from
colon fecal samples of pigs. E. coli O157 has also been
isolated from horses, cats and dogs. In all cases, these
animals are housed on farms which also house cattle
(Chalmers et al., 1997; Trevena et al., 1996). 
Wild animals
Besides from domestic animals, EHEC have been
isolated from a variety of wild animals, such as rabbits
and deer. In the United Kingdom, visitors to a wildlife
park became infected with EHEC O157. This outbreak
was associated with feces from wild rabbits, living in
an adjacent field together with E. coli O157 positive
cattle. This outbreak revealed that wild rabbits can
also act as vectors. Fischer et al. (2001) detected EHEC
O157 in 0.6% of the feces of white-tailed deer. The
consumption of jerky made from deer meat has also
been associated with human infections (Keene et al.,
1997). These outbreaks associated with wild animals
highlight the potential role that wild animals can play
in the transmission of EHEC.
TRANSMISSION OF EHEC
There are four main transmission routes identified
through which EHEC can be transmitted to humans: (1)
foodborne transmission; (2) waterborne transmission;
(3) person-to-person transmission; and (4) direct con-
tact with animals. 
Foodborne transmission
Most outbreaks of EHEC infections are caused by
inadequately cooked hamburgers or other beef products,
and unpasteurized milk. Dairy products asso ciated with
outbreaks are those that are unpasteurized, had a pas-
teurization failure or were contaminated after pasteuri-
zation. The latter can be illustrated by a ice cream-rela-
ted outbreak in Belgium (Buvens et al., 2011). Over the
last years, the contribution of other food vehicles has
increased. For example, outbreaks have been associated
with fermented sausages, apple juice, mayonnaise and
yoghurt. These outbreaks highlight the acid tolerance
and the ability to survive the process of fermentation
and drying of EHEC O157 strains. Fresh produce can
be contaminated by direct contact with fecally conta-
minated soil, agricultural run-off or irrigation water.
Noteworthy, the use of agricultural run-off water for ir-
rigation is prohibited in Europe.  In 2006, a multistate
outbreak of E. coli O157 occurred in the United States.
Fresh baby spinach, contaminated by feces of wild
boars, was identified as the source of the outbreak, in-
volving 183 persons (Jay et al., 2007). 
Waterborne transmission
Water is a very efficient vehicle for the dissemination
of EHEC. Surface waters may be subjected to EHEC
contamination through run-off from pastures and from
direct deposition of fecal material on the agricultural
land. Water close to cattle herds may therefore present
a potential reservoir of EHEC allowing the pathogen to
spread in the environment. For example, in many coun-
tries, the river water is contaminated with a huge load
of treated and untreated manure. Recently, E. coli
O157:H7 has been detected in the Ganges River (Ham-
ner et al., 2007). Contaminated water as a source of
EHEC infection may occur as a result of drinking (Bopp
et al., 2003; Olsen et al., 2002) and swimming water
(Samadpour et al., 2002). The largest waterborne out-
break occurred in Canada in 2000. The outbreak led to
seven deaths and more than 2300 illnesses (Hrudey et
al., 2003). The drinking water supply was contaminated
by rainwater run-off containing cattle feces. Several of
the drinking water outbreaks occurred in water systems
without proper chlorination. 
Person-to-person transmission
Since the infectious dose is low (1 to 100 cells) per-
son-to-person can easily occur through fecal-oral trans-
mission following a primary case). Person-to-person
transmission has emerged in day-care facilities as the
predominant route of EHEC outbreaks (O’Donnell et
al., 2002; Reida et al., 1994). It has been demonstrated
that infected humans may shed EHEC for several
weeks following resolution of the clinical features
(Mead and Griffin, 1998). This prolonged shedding
tends to be more pronounced in young children, ex-
plaining the outbreaks in day-care facilities. Further-
more, EHEC infections can occur asymptomatically.
Secondary transmission by the primary case in a house-
hold is therefore a particular concern. 
Contact with animals
Several EHEC outbreaks have been associated with
animal exhibits at fairs, zoos and other venues resulting
from direct contact with the animals and their envi-
ronment followed by inadequate hand washing. Con-
tact with pets has also been a route of EHEC infection.
In Germany, a 2-year-old girl with bloody diarrhoea
was found to excrete EHEC. Repeated stool samples
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from her cat yielded a strain of EHEC O145:H– that
showed the identical pathogenicity gen pattern as the
girl’s isolate. Although the cat had no symptoms, it ex-
creted this strain for several months and was apparently
the source of the girl’s original infection and/or rein-
fection (Busch et al., 2007).
OUTBREAK IN GERMANY, MAY 2011
Early May 2011, an unusually high number of HUS
cases were reported in Germany. The outbreak strain
was in facto not an EHEC strain as repeatedly repor-
ted in popular media, but shared characteristics of
EAEC and VTEC. Strains with combinations of viru-
lence properties from different pathotypes have been
described before, but the size and severity of the out-
break have highlighted the importance and unpredic-
tability of the consequences of genetic exchange be-
tween pathotypes. 
The outbreak strain
The outbreak strain has been characterized very
thoroughly at the Robert Koch Institute. The strain is of
serotype O104:H4 and evolves from a progenitor that
belongs to the enteroaggregative pathotype. The emer-
gence of the outbreak strain depends on the acquisition
of a vtx2 prophage and of a plasmid encoding CTX-M-
15 ESBL (Rohde et al., 2011). The outbreak strain pos-
sesses therefore an unusual combination of virulence
factors of EAEC and EHEC. This combination is very
rare and has previously been described in strains of se-
rotype O111:H2 involved in a small outbreak of HUS
in children in France (Morabito et al., 1998). It re-
mains unclear why this strain has proven to be so viru-
lent. However, it is conceivable that the enteroaggre-
gative phenotype rendered these O104:H4 strains to
colonize the intestinal mucosa as efficiently as the ty-
pical eae-positive EHEC strains. The augmented ad-
herence of the strain to the intestinal epithelium might
facilitate the systemic absorption of the verocytotoxins
and could explain the high progression to HUS (Bie-
laszewska et al., 2011).  
Outbreak description
On May 22th 2011, Germany reported a significant
increase in patients with bloody diarrhoea and HUS.
During the succeeding month, thousands of infections
occurred resulting in 3128 non-HUS cases, 782 cases
of HUS and 46 deaths. The Robert Koch Institute sta-
ted on July 26th the outbreak in Germany as officially
over, as the last onset of disease to be attributed to the
outbreak was reported on the 4th of  July 2011. Up to
125 infections with 49 cases of HUS caused by the out-
break strain have been reported in other European
countries including, Austria, the Czech Republic, Den-
mark, France, Greece, Luxembourg, the Netherlands,
Norway, Poland, Spain, Sweden and the United King-
dom. Most patients appeared to be travellers returning
from Germany. 
Of particular interest, O104:H4 cases showed an
uneven sex distribution, with a preponderance of wo-
men in both non-HUS infections (59%) and HUS
(68%) cases. In addition, people over 20 years of age
account for the vast majority of the cases (88%). This
sex and age predominance might be related to gender-
specific differences in dietary habits, namely vegeta-
bles are generally more often consumed by adult wo-
men. Other particular features of this outbreak are the
high percentage of HUS cases (20-25% instead of 5-
6%), common severe neurological complications and
non-HUS deaths. 
On June 24th, France also reported a cluster of E.
coli O104:H4 infections among people who attended
an open day at a children’s community center in Bor-
deaux. All patients reported eating sprouts served at the
event. The European Food Safety Agency (EFSA) con-
ducted a comprehensive investigation to identify the
source of the two outbreaks (EFSA, 2011). The analy-
sis of the investigation identified a single lot of fenu-
greek seeds, from an exporter in Egypt, as the most li-
kely source of the sprouts linked to the two outbreaks.
CONCLUSION
The knowledge of the epidemiology and ecology of
EHEC is far from complete. To date, EHEC research
has focused mainly on EHEC O157 in cattle. However,
EHEC O157 and non-O157 have been reported in
many other animal species. New routes of transmission
have also emerged, such as contact with animals during
farm visits, contact with pets and a wide variety of en-
vironment-related exposures. In order to inform risk as-
sessment, further research into non-bovine animal spe-
cies, foodstuffs or environmental vehicles should be
considered and tested. 
The main conclusion from the German outbreak is
that E. coli strains belonging to different pathotypes al-
lowed for the emergence of the highly virulent verocy-
totoxin–producing enteroaggregative E. coli O104:H4
strain. Epidemiologists and microbiologists face many
challenges of detecting strains belonging to different pa-
thotypes and in preventing and managing future out-
breaks of such strains.
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